Your browser doesn't support javascript.
loading
Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
Naggie, Susanna; Boulware, David R; Lindsell, Christopher J; Stewart, Thomas G; Slandzicki, Alex J; Lim, Stephen C; Cohen, Jonathan; Kavtaradze, David; Amon, Arch P; Gabriel, Ahab; Gentile, Nina; Felker, G Michael; Jayaweera, Dushyantha; McCarthy, Matthew W; Sulkowski, Mark; Rothman, Russell L; Wilson, Sybil; DeLong, Allison; Remaly, April; Wilder, Rhonda; Collins, Sean; Dunsmore, Sarah E; Adam, Stacey J; Thicklin, Florence; Hanna, George J; Ginde, Adit A; Castro, Mario; McTigue, Kathleen; Shenkman, Elizabeth; Hernandez, Adrian F.
Affiliation
  • Naggie S; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
  • Boulware DR; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
  • Lindsell CJ; Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis.
  • Stewart TG; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Slandzicki AJ; School of Data Science, University of Virginia, Charlottesville.
  • Lim SC; Clinical Trials Center of Middle Tennessee, Franklin.
  • Cohen J; University Medical Center New Orleans, Louisiana State University Health Sciences Center, New Orleans.
  • Kavtaradze D; Jadestone Clinical Research, LLC, Silver Spring, Maryland.
  • Amon AP; David Kavtaradze, Inc, Cordele, Georgia.
  • Gabriel A; Lakeland Regional Medical Center, Lakeland, Florida.
  • Gentile N; Focus Clinical Research Solutions, Charlotte, North Carolina.
  • Felker GM; Department of Emergency Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.
  • Jayaweera D; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
  • McCarthy MW; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
  • Sulkowski M; Department of Medicine, Miller School of Medicine, University of Miami, Miami, Florida.
  • Rothman RL; Weill Cornell Medicine, New York, New York.
  • Wilson S; Division of Infectious Diseases, Johns Hopkins University, Baltimore, Maryland.
  • DeLong A; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Remaly A; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
  • Wilder R; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
  • Collins S; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
  • Dunsmore SE; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
  • Adam SJ; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Thicklin F; Veterans Affairs Tennessee Valley Healthcare System, Geriatric Research, Education and Clinical Center (GRECC), Nashville.
  • Hanna GJ; National Center for Advancing Translational Sciences, Bethesda, Maryland.
  • Ginde AA; Foundation for the National Institutes of Health, Bethesda, Maryland.
  • Castro M; Stakeholder Advisory Committee, Pittsburgh, Pennsylvania.
  • McTigue K; Biomedical Advanced Research and Development Authority, Washington, DC.
  • Shenkman E; University of Colorado School of Medicine, Aurora.
  • Hernandez AF; Division of Pulmonary, Critical Care and Sleep Medicine, University of Missouri-Kansas City School of Medicine, Kansas City.
JAMA ; 329(11): 888-897, 2023 03 21.
Article in En | MEDLINE | ID: mdl-36807465
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: JAMA Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: JAMA Year: 2023 Document type: Article